Report Prepared Matt Stenger

Article

Mechlorethamine gel for early stage mycosis fungoides-type CTCL

Author:: Report Prepared Matt Stenger

Publish date: August 27, 2014

Article

Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations

Author:: Report Prepared Matt Stenger

Publish date: July 22, 2014

Article

Cobas HPV test for first-line screening for cervical cancer

Author:: Report Prepared Matt Stenger

Publish date: May 27, 2014

Article

Obinutuzumab for previously untreated chronic lymphocytic leukemia

Author:: Report Prepared Matt Stenger

Publish date: April 22, 2014

Obinutuzumab was approved by the Food and Drug Administration in late 2013 for use in combination with chlorambucil for the treatment of patie...

Article

Pertuzumab in neoadjuvant treatment of HER2-positive early breast cancer

Author:: Report Prepared Matt Stenger

Publish date: March 26, 2014

Pertuzumab injection was granted accelerated approval by the US Food and Drug Administration last fall for use in combination with trastuzumab plus...

Article

Dabrafenib in advanced melanoma with BRAF V600E mutation

Author:: Report Prepared Matt Stenger

Publish date: February 20, 2014

Dabrafenib was recently approved by the US Food and Drug Administration for treatment of unresectable or metastatic melanoma with BRAF V600E mutati...

Article

Afatinib in metastatic NSCLC with mutations

Author:: Report Prepared Matt Stenger

Publish date: February 4, 2014

In July 2013, afatinib was approved by the US Food and Drug Administration for first-line treatment of patients with metastatic non–small-cell lung...